AbbVie Inc.
ABBVNYSECIK 1551152HealthcareFiscal year ends Dec 31
Reports and events: 276 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3007:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000033 |
| 2026-10-1516:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-116227 |
| 2026-10-0516:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000030 |
| 2026-09-0308:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-104940 |
| 2026-08-1816:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-098367 |
| 2026-08-0517:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-091269 |
| 2026-08-0314:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001551152-26-000026 |
| 2026-07-3107:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000023 |
| 2026-07-0616:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000021 |
| 2026-06-2207:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-076067 |
| 2026-05-1217:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-059484 |
| 2026-05-0812:28 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001551152-26-000017 |
| 2026-04-2907:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000013 |
| 2026-04-0316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000011 |
| 2026-03-2316:59 ET | DEF 14A | Proxy statementPeriod 2026-05-08 | 0001104659-26-033387 |
| 2026-03-0416:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-023534 |
| 2026-02-2617:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-020643 |
| 2026-02-2014:38 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001551152-26-000008 |
| 2026-02-0407:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000004 |
| 2026-01-0716:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-26-000002 |
| 2025-11-0414:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001551152-25-000049 |
| 2025-10-3107:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000047 |
| 2025-10-0316:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000043 |
| 2025-09-1107:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-089245 |
| 2025-08-0415:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001551152-25-000040 |
| 2025-07-3107:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000036 |
| 2025-07-0313:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000034 |
| 2025-05-1317:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-25-047402 |
| 2025-05-0913:24 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001551152-25-000029 |
| 2025-04-2507:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000026 |
| 2025-04-0316:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000023 |
| 2025-03-2416:28 ET | DEF 14A | Proxy statementPeriod 2025-05-09 | 0001558370-25-003537 |
| 2025-02-2617:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-017490 |
| 2025-02-1909:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-015015 |
| 2025-02-1413:17 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001551152-25-000020 |
| 2025-02-1407:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-013467 |
| 2025-02-0516:15 ET | 8-K | 8.01 Other events | 0001104659-25-009673 |
| 2025-01-3107:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000011 |
| 2025-01-1008:31 ET | 8-K | 2.06 Material impairments | 0001551152-25-000006 |
| 2025-01-0616:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-25-000002 |
| 2024-12-1316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-128413 |
| 2024-11-0414:19 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001551152-24-000040 |
| 2024-10-3007:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000036 |
| 2024-10-0316:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000033 |
| 2024-09-1015:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-098564 |
| 2024-08-0715:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001551152-24-000031 |
| 2024-07-2507:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000026 |
| 2024-07-0314:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000024 |
| 2024-05-0817:00 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-24-058808 |
| 2024-05-0311:04 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001551152-24-000020 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 07:53 ET. Listed shows no prices and gives no investment advice.